Tools
Stock profile

BRUKER CORP (BRKR)

BRKR · Latest close $63.26 as of Nov 18, 2026 · 13F data as of Jun 30, 2026 (2026 Q2)
Latest close
$63.26
As of Nov 18, 2026
Tracked funds holding
2 of 149
2026 Q2 13F filings
Opened / added
1 / 0
vs previous quarter
Trimmed / exited
1
vs previous quarter

BRUKER CORP (BRKR) is held by 2 of 149 tracked super-investor funds (144 filed in Q2) in 2026 Q2 13F filings, with 1 fund opening new positions and 1 fund trimming or exiting versus the previous quarter. Insiders were net sellers over the last 90 days ($0 bought vs $105.7K sold). Latest close $63.26 as of Nov 18, 2026.

Data as of Nov 18, 2026 (prices) · 2026 Q2 13F filings (quarter ended Jun 30, 2026) · Latest Form 4: Sep 15, 2026 · Congress to Nov 16, 2026.

Funds
2026 Q2 13F
Insiders · 90d
net $-105.7K
Fundamentals
Revenue · FY2025
Red flags
none flagged
Short interest
as of Oct 15, 2026
Holdings · Charts · All institutions · Fundamentals · Short interest · Fails to deliver · Insider trading · 5% holders · Planned sales · Politician trading · Committee jurisdiction · Government relations · Screens & lenses · Signal record · Related stocks · Recent 8-K

Funds holding this

Samlyn Capital · Viking Global Investors — 2 tracked funds hold BRKR. See all holders.

Insider and Congress activity

Insiders bought on the open market (0 purchases, $0) vs 1 sale ($105.7K). Insider trading

Often held alongside

WATERS CORP /DE/ (WAT) · Avantor, Inc. (AVTR) · BIO-RAD LABORATORIES, INC. (BIO) · AGILENT TECHNOLOGIES, INC. (A) · ILLUMINA, INC. (ILMN) — stocks the same funds also hold. See all related stocks.

Super-investor holdings · 2026 Q2

FundPortfolio weightSharesChange vs prev. quarter
Samlyn Capital0.33%337,264TRIMMED (-78.1%) Q3 filed Nov 16
Viking Global Investors0.15%893,491NEW Q3 filed Nov 16

Source: SEC Form 13F filings, quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. Fund counts aggregate every share class mapped to this ticker.

Price change since quarter-end: +1.2% from the close on the first trading day after the quarter ended (Jul 1, 2026) to the latest close (Nov 17, 2026). 13F does not report purchase prices — this is the price change since the quarter-end close, not a gain on any fund’s actual purchase.

Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.

Charts

66.5427.862024-11-192026-11-18

Closing prices (unadjusted for dividends), last 2 years — 501 trading days to Nov 18, 2026. Dashed lines mark 13F filing deadlines. Source: Yahoo Finance daily bars.

All institutions · Form 13F

Institutions holding416 of 8,857 filers
Long-only filers among them414
Change vs 2026 Q1+80 net · 403 entered · 323 exited
Shares reported, all filers141,736,811
Reported value, all filers$8.4B

Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).

Company fundamentals

ExchangeNasdaq
IndustryLaboratory Analytical Instruments (SIC 3826)
Revenue · FY2025$3.4B
Net income · FY2025$-8.6M
Total assets · FY2025$6.2B
Shares outstanding151,719,365
Market cap (at latest close)$9.6B

Source: SEC EDGAR company filings (submissions and company facts), collected Oct 30, 2026. Shares outstanding as reported Jul 29, 2025.

Short interest

Shares short · Oct 15, 202612,673,281
Share of shares outstanding8.35%
Days to cover5.71

Shares short at recent settlements — Jul 31, 2026: 12.7M · Aug 14, 2026: 11.8M · Aug 31, 2026: 12.0M · Sep 15, 2026: 12.5M · Sep 30, 2026: 12.4M · Oct 15, 2026: 12.7M.

Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Jul 29, 2025.

Fails to deliver

Shares failed to deliver · Oct 14, 20260
Share of shares outstanding0.00%
Fails as a share of short interest · Oct 15, 20260.0%

Fails to deliver at recent settlements — Jul 31, 2026: 0 · Aug 14, 2026: 22K · Aug 31, 2026: 16K · Sep 15, 2026: 0 · Sep 30, 2026: 40K · Oct 14, 2026: 0.

Source: SEC Fails-to-Deliver data (semi-monthly files, published about two weeks after each settlement date). Each figure is the balance of shares not yet delivered on that date; a stock absent from that date’s file counts as zero. See our research on whether fails to deliver predict returns. Shares outstanding from SEC filings as of Jul 29, 2025.

Insider trading · Form 4

0 insiders bought on the open market in the last 90 days (0 purchases, $0), against 1 sale by 1 insider ($105.7K).

Source: SEC Form 4 filings. Open-market transactions only.

Recent open-market trades

DateInsiderRoleBuy / SellSharesPriceValueSource
Sep 15, 2026Munch MarkEXEC VP&PRES BRUKER NANO INC.Sell2,000$52.87$105.7KSEC filing

Most recent open-market transactions in the same 90-day window, most recent first. Source: SEC Form 4 filings.

Planned sales · Form 144

FiledSellerRoleShares to sellMarket valueApprox. sale dateSource
Sep 15, 2026MARK R MUNCHOfficer2,000$105.7KSep 15, 2026SEC filing
Aug 17, 2026WOLFGANG PUSCHOfficer3,473$197.6KAug 17, 2026SEC filing
Aug 14, 2026MARK R MUNCHOfficer2,000$115.2KAug 14, 2026SEC filing
Jul 15, 2026MARK R MUNCHOfficer2,000$120.5KJul 15, 2026SEC filing
Jun 15, 2026MARK R MUNCHOfficer2,000$109.5KJun 15, 2026SEC filing
May 15, 2026MARK R MUNCHOfficer2,000$87.8KMay 15, 2026SEC filing
Apr 15, 2026MARK R MUNCHOfficer2,000$79.8KApr 15, 2026SEC filing
Mar 13, 2026MARK R MUNCHOfficer2,000$70.9KMar 13, 2026SEC filing
Feb 13, 2026MARK R MUNCHOfficer2,000$73.9KFeb 13, 2026SEC filing
Jan 15, 2026MARK R MUNCHOfficer2,000$98.4KJan 15, 2026SEC filing

A Form 144 notice is a planned sale, not a completed sale. Most recent first. Source: SEC Form 144 filings, 63,013 notices from Apr 13, 2023 to Oct 9, 2026.

5% holders · Schedule 13D/G

FiledFilerFormShares% ownedEvent dateSource
Aug 6, 2026FMR LLCSC 13G/A23,296,465.5515.0%Jun 30, 2026SEC filing
May 15, 2026ORBIS INVESTMENT MANAGEMENT LTDSC 13G/A16,852,86811.1%Mar 31, 2026SEC filing
May 6, 2026FMR LLCSC 13G/A19,208,582.4112.4%Mar 31, 2026SEC filing
Mar 26, 2026The Vanguard GroupSC 13G/A00.0%Mar 13, 2026SEC filing
Mar 6, 2026ORBIS INVESTMENT MANAGEMENT LTDSC 13G/A15,197,86610.0%Feb 28, 2026SEC filing
Feb 17, 2026T. Rowe Price Investment Management, Inc.SC 13G/A4,594,3983.0%Dec 31, 2025SEC filing
Feb 17, 2026ORBIS INVESTMENT MANAGEMENT LTDSC 13G/A14,077,8959.3%Dec 31, 2025SEC filing
Nov 14, 2025T. Rowe Price Investment Management, Inc.SC 13G/A7,787,2995.1%Sep 30, 2025SEC filing
Nov 14, 2025ORBIS INVESTMENT MANAGEMENT LTDSC 13G13,393,9098.8%Sep 30, 2025SEC filing
Oct 7, 2025FMR LLCSC 13G/A17,082,319.911.0%Sep 30, 2025SEC filing

One filing is one row; a filing may list several reporters and the first is shown. Figures are as filed, including amendments that report zero shares after a transfer. Source: SEC Schedule 13D/G filings, 57,443 filings parsed to Oct 2, 2026.

Politician trading · U.S. Congress

Data unavailable — no congressional STOCK Act transactions for this ticker were parsed in the current window (as of Nov 16, 2026).

Committee jurisdiction

Industry: Laboratory Analytical Instruments (SIC 3826). No standing committee maps to this industry under the site’s jurisdiction rule — see Methodology.

Assignments are the current (119th Congress) rosters. A trade made in an earlier Congress may have been made under a different assignment. Jurisdiction is by industry (SEC SIC code), not by anything the company said or did. Same rule as our committee-jurisdiction study.

Government relations

Lobbying: no Lobbying Disclosure Act filings matched for this ticker (1999–2026).

Federal contracts: $71.9M in obligated amounts, fiscal years 2021–2026.

Fiscal yearObligated amount
FY2021$16.3M
FY2022$15.8M
FY2023$29.4M
FY2024$10.1M
FY2025$426.1K
FY2026$-23.8K

Largest awards collected

Award IDAgencyAmountStart
W911SR19F0003Department of Defense$11.9MOct 26, 2018
HSHQDC16CB0002Department of Homeland Security$6.0MJan 5, 2016
75N95019P00664Department of Health and Human Services$3.7MSep 17, 2019
75N94019P00760Department of Health and Human Services$2.9MAug 26, 2019
75N92024P00353Department of Health and Human Services$2.8MSep 16, 2024

Lobbying filings are matched by company core name; a filing can match more than one ticker. Contract amounts are obligated amounts (money committed, not money spent), matched by recipient name — contracts under a subsidiary’s name can be missed. Sources: Senate Lobbying Disclosure Act filings; USAspending.gov. See Methodology.

Screens & lenses

Financial Screens

· Growth — Revenue up every year for 5 straight years

· Dividend Growth — Dividends raised for more than 10 years

Chart Signals

· Monthly Uptrend — Price above its 12-month moving average

· Top Relative Strength — Top 20% of the universe by 6-month return

Key figures

· Growth — Latest revenue: $3.4B · 5-yr revenue CAGR: 11.6% · Straight growth years: 5

· Dividend Growth — Dividend per share: 0.20 · Dividend yield: 0.3% · Straight dividend years: 9 · 10-yr dividend growth: —

Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.

Also held by the tracked funds that hold BRKR — ranked by lift, the co-holding pattern described in Methodology: WATERS CORP /DE/ (WAT) · Avantor, Inc. (AVTR) · BIO-RAD LABORATORIES, INC. (BIO) · AGILENT TECHNOLOGIES, INC. (A) · ILLUMINA, INC. (ILMN) · METTLER TOLEDO INTERNATIONAL INC/ (MTD) · 908 Devices Inc. (MASS) · Quanterix Corp (QTRX).

8 of the 8 are same-industry (SIC) fillers: fewer than 4 stocks met the lift rule for this stock.

Recent 8-K filings

FiledItemsSource
Nov 16, 20265.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers · 8.01 Other Events · 9.01 Financial Statements and ExhibitsSEC filing
Nov 5, 20268.01 Other Events · 9.01 Financial Statements and ExhibitsSEC filing
Nov 4, 20262.02 Results of Operations and Financial Condition · 9.01 Financial Statements and ExhibitsSEC filing

Source: SEC EDGAR Form 8-K filings, latest first. Amendments (Form 8-K/A) are labeled as such. Item labels are the SEC's item titles; a filing can carry several items. Item 5.02 covers both departures and appointments, which this index does not distinguish.

Related

WATERS CORP /DE/ (WAT) · Track Record: how the signals scored · Practice timing on BRKR

One email a week: the week’s new filings and research. Subscribe free

← BRK.B  ·  BRO →

Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.